Patricia J. SimnerJohann D. D. PitoutTanis C. Dingle1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA2Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA3Cummings School of Medicine, University of Calgary, Calgary, Calgary, Alberta, Canada4Alberta Precision Laboratories, Diagnostic Laboratory, Calgary, Alberta, Canada5University of Pretoria, Pretoria, Gauteng, South Africa6Alberta Precision Laboratories, Public Health Laboratory, Calgary, Alberta, CanadaGraeme N. ForrestChristopher PfeifferKevin Alby
Clinical Microbiology Reviews, Ahead of Print.
临床微生物学评论》，提前出版。
{"title":"Laboratory detection of carbapenemases among Gram-negative organisms","authors":"Patricia J. SimnerJohann D. D. PitoutTanis C. Dingle1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA2Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA3Cummings School of Medicine, University of Calgary, Calgary, Calgary, Alberta, Canada4Alberta Precision Laboratories, Diagnostic Laboratory, Calgary, Alberta, Canada5University of Pretoria, Pretoria, Gauteng, South Africa6Alberta Precision Laboratories, Public Health Laboratory, Calgary, Alberta, CanadaGraeme N. ForrestChristopher PfeifferKevin Alby","doi":"10.1128/cmr.00054-22","DOIUrl":"https://doi.org/10.1128/cmr.00054-22","url":null,"abstract":"Clinical Microbiology Reviews, Ahead of Print. <br/>","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"50 1","pages":""},"PeriodicalIF":36.8,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142637587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Archie A. KhanMartin C. TaylorAmanda Fortes FranciscoShiromani JayawardhanaRichard L. AthertonFrancisco OlmoMichael D. LewisJohn M. Kelly1Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United KingdomLouisa A. MessengerValeria Tekiel
Clinical Microbiology Reviews, Ahead of Print.
临床微生物学评论》，提前出版。
{"title":"Animal models for exploring Chagas disease pathogenesis and supporting drug discovery","authors":"Archie A. KhanMartin C. TaylorAmanda Fortes FranciscoShiromani JayawardhanaRichard L. AthertonFrancisco OlmoMichael D. LewisJohn M. Kelly1Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United KingdomLouisa A. MessengerValeria Tekiel","doi":"10.1128/cmr.00155-23","DOIUrl":"https://doi.org/10.1128/cmr.00155-23","url":null,"abstract":"Clinical Microbiology Reviews, Ahead of Print. <br/>","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"70 1","pages":""},"PeriodicalIF":36.8,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142637588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yuan-Ping Deng,Yi-Tian Fu,Hany M Elsheikha,Mei-Ling Cao,Xing-Quan Zhu,Jin-Lei Wang,Xue-Ling Zhang,Shi-Chen Xie,Chaoqun Yao,Guo-Hua Liu
SUMMARYTick paralysis is a potentially fatal condition caused by neurotoxins secreted by the salivary glands of certain ticks. Documented cases have been reported worldwide, predominantly in the United States, Canada, and Australia, with additional reports from Europe and Africa. This condition also affects animals, leading to significant economic losses and adverse impacts on animal health and welfare. To date, 75 tick species, mostly hard ticks, have been identified as capable of causing this life-threatening condition. Due to symptom overlap with other conditions, accurate diagnosis of tick paralysis is crucial to avoid misdiagnosis, which could result in adverse patient outcomes. This review provides a comprehensive analysis of the current literature on tick paralysis, including the implicated tick species, global distribution, tick toxins, molecular pathogenesis, clinical manifestations, diagnosis, treatment, control, and prevention. Enhancing awareness among medical and veterinary professionals is critical for improving the management of tick paralysis and its health impacts on both humans and animals.
{"title":"Comprehensive analysis of the global impact and distribution of tick paralysis, a deadly neurological yet fully reversible condition.","authors":"Yuan-Ping Deng,Yi-Tian Fu,Hany M Elsheikha,Mei-Ling Cao,Xing-Quan Zhu,Jin-Lei Wang,Xue-Ling Zhang,Shi-Chen Xie,Chaoqun Yao,Guo-Hua Liu","doi":"10.1128/cmr.00074-24","DOIUrl":"https://doi.org/10.1128/cmr.00074-24","url":null,"abstract":"SUMMARYTick paralysis is a potentially fatal condition caused by neurotoxins secreted by the salivary glands of certain ticks. Documented cases have been reported worldwide, predominantly in the United States, Canada, and Australia, with additional reports from Europe and Africa. This condition also affects animals, leading to significant economic losses and adverse impacts on animal health and welfare. To date, 75 tick species, mostly hard ticks, have been identified as capable of causing this life-threatening condition. Due to symptom overlap with other conditions, accurate diagnosis of tick paralysis is crucial to avoid misdiagnosis, which could result in adverse patient outcomes. This review provides a comprehensive analysis of the current literature on tick paralysis, including the implicated tick species, global distribution, tick toxins, molecular pathogenesis, clinical manifestations, diagnosis, treatment, control, and prevention. Enhancing awareness among medical and veterinary professionals is critical for improving the management of tick paralysis and its health impacts on both humans and animals.","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"4 1","pages":"e0007424"},"PeriodicalIF":36.8,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142488226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E Wilbur Woodhouse,Micah T McClain,Christopher W Woods
SUMMARYDetection of the presence of infection and its etiology must be accurate and timely to facilitate appropriate antimicrobial use. Diagnostic strategies that rely solely on pathogen detection often are insufficient due to poor test characteristics, inability to differentiate colonization from infection, or protracted delay to result. Understanding the human response across different pathogens on a clinical and molecular level can provide more accurate, timely, and useful answers, especially in critical illness and diagnostic uncertainty. Improvements in understanding the human immune response including genomics, protein analysis, gene expression, and cellular morphology have led to rapid innovation of new host response-based diagnostic tests. This review describes the limitations of pathogen-focused technology and the benefits of examining the breadth of immune response to diagnose infection. It then explores biomarkers that have been studied for this purpose and scrutinizes the performance of host-based multianalyte testing. Currently cleared diagnostics and those in late-stage development are described in depth, with a focus on the purpose of testing and its utility for clinicians. Finally, it concludes by examining opportunities for further host response-derived diagnostic innovation.
{"title":"Harnessing the host response for precision infectious disease diagnosis.","authors":"E Wilbur Woodhouse,Micah T McClain,Christopher W Woods","doi":"10.1128/cmr.00078-24","DOIUrl":"https://doi.org/10.1128/cmr.00078-24","url":null,"abstract":"SUMMARYDetection of the presence of infection and its etiology must be accurate and timely to facilitate appropriate antimicrobial use. Diagnostic strategies that rely solely on pathogen detection often are insufficient due to poor test characteristics, inability to differentiate colonization from infection, or protracted delay to result. Understanding the human response across different pathogens on a clinical and molecular level can provide more accurate, timely, and useful answers, especially in critical illness and diagnostic uncertainty. Improvements in understanding the human immune response including genomics, protein analysis, gene expression, and cellular morphology have led to rapid innovation of new host response-based diagnostic tests. This review describes the limitations of pathogen-focused technology and the benefits of examining the breadth of immune response to diagnose infection. It then explores biomarkers that have been studied for this purpose and scrutinizes the performance of host-based multianalyte testing. Currently cleared diagnostics and those in late-stage development are described in depth, with a focus on the purpose of testing and its utility for clinicians. Finally, it concludes by examining opportunities for further host response-derived diagnostic innovation.","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"3 1","pages":"e0007824"},"PeriodicalIF":36.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142439452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. J. WhiteK. Chotivanich1Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand2Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom3Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, ThailandFerric C. FangSunil Parikh
Clinical Microbiology Reviews, Ahead of Print.
临床微生物学评论》，提前出版。
{"title":"Artemisinin-resistant malaria","authors":"N. J. WhiteK. Chotivanich1Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand2Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom3Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, ThailandFerric C. FangSunil Parikh","doi":"10.1128/cmr.00109-24","DOIUrl":"https://doi.org/10.1128/cmr.00109-24","url":null,"abstract":"Clinical Microbiology Reviews, Ahead of Print. <br/>","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"93 1","pages":""},"PeriodicalIF":36.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142440636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sabine E Olie,Christian Ø Andersen,Diederik van de Beek,Matthijs C Brouwer
SUMMARYCentral nervous system (CNS) infections can be caused by various pathogens, including bacteria, viruses, fungi, and parasites. Molecular diagnostic methods are pivotal for identifying the different causative pathogens of these infections in clinical settings. The efficacy and specificity of these methods can vary per pathogen involved, and in a substantial part of patients, no pathogen is identified in the cerebrospinal fluid (CSF). Over recent decades, various molecular methodologies have been developed and applied to patients with CNS infections. This review provides an overview of the accuracy of nucleic acid amplification methods in CSF for a diverse range of pathogens, examines the potential value of multiplex PCR panels, and explores the broad-range bacterial and fungal PCR/sequencing panels. In addition, it evaluates innovative molecular approaches to enhance the diagnosis of CNS infections.
{"title":"Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections.","authors":"Sabine E Olie,Christian Ø Andersen,Diederik van de Beek,Matthijs C Brouwer","doi":"10.1128/cmr.00021-24","DOIUrl":"https://doi.org/10.1128/cmr.00021-24","url":null,"abstract":"SUMMARYCentral nervous system (CNS) infections can be caused by various pathogens, including bacteria, viruses, fungi, and parasites. Molecular diagnostic methods are pivotal for identifying the different causative pathogens of these infections in clinical settings. The efficacy and specificity of these methods can vary per pathogen involved, and in a substantial part of patients, no pathogen is identified in the cerebrospinal fluid (CSF). Over recent decades, various molecular methodologies have been developed and applied to patients with CNS infections. This review provides an overview of the accuracy of nucleic acid amplification methods in CSF for a diverse range of pathogens, examines the potential value of multiplex PCR panels, and explores the broad-range bacterial and fungal PCR/sequencing panels. In addition, it evaluates innovative molecular approaches to enhance the diagnosis of CNS infections.","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"7 1","pages":"e0002124"},"PeriodicalIF":36.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142439450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Axel KramerFranziska LexowAnna BludauAntonia Milena KösterMartin MisailovskiUlrike SeifertMaren EggersWilliam RutalaStephanie J. DancerSimone Scheithauer1Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany2Department for Infectious Diseases, Unit 14: Hospital Hygiene, Infection Prevention and Control, Robert Koch Institute, Berlin, Germany3Department of Infection Control and Infectious Diseases, University Medical Center Göttingen (UMG), Georg-August University Göttingen, Göttingen, Germany4Department of Geriatrics, University of Göttingen Medical Center, Göttingen, Germany5Friedrich Loeffler-Institute of Medical Microbiology – Virology, University Medicine Greifswald, Greifswald, Germany6Labor Prof. Dr. G. Enders MVZ GbR, Stuttgart, Germany7Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA8Department of Microbiology, University Hospital Hairmyres, Glasgow, United..
Clinical Microbiology Reviews, Ahead of Print.
临床微生物学评论》，提前出版。
{"title":"How long do bacteria, fungi, protozoa, and viruses retain their replication capacity on inanimate surfaces? A systematic review examining environmental resilience versus healthcare-associated infection risk by “fomite-borne risk assessment”","authors":"Axel KramerFranziska LexowAnna BludauAntonia Milena KösterMartin MisailovskiUlrike SeifertMaren EggersWilliam RutalaStephanie J. DancerSimone Scheithauer1Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany2Department for Infectious Diseases, Unit 14: Hospital Hygiene, Infection Prevention and Control, Robert Koch Institute, Berlin, Germany3Department of Infection Control and Infectious Diseases, University Medical Center Göttingen (UMG), Georg-August University Göttingen, Göttingen, Germany4Department of Geriatrics, University of Göttingen Medical Center, Göttingen, Germany5Friedrich Loeffler-Institute of Medical Microbiology – Virology, University Medicine Greifswald, Greifswald, Germany6Labor Prof. Dr. G. Enders MVZ GbR, Stuttgart, Germany7Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA8Department of Microbiology, University Hospital Hairmyres, Glasgow, United..","doi":"10.1128/cmr.00186-23","DOIUrl":"https://doi.org/10.1128/cmr.00186-23","url":null,"abstract":"Clinical Microbiology Reviews, Ahead of Print. <br/>","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"13 1","pages":""},"PeriodicalIF":36.8,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142398288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alice S Weissfeld,Vickie Baselski,Nancy E Cornish,Colleen S Kraft,Mark T LaRocco,Peggy McNult,Irving Nachamkin,James Scott Parrott,Sandra S Richter,Matthew Rubinstein,Michael A Saubolle,Robert L Sautter,James W Snyder,Joanna Taliano,Donna M Wolk
SUMMARYClinical medicine has embraced the use of evidence for patient treatment decisions; however, the evaluation strategy for evidence in laboratory medicine practices has lagged. It was not until the end of the 20th century that the Institute of Medicine (IOM), now the National Academy of Medicine, and the Centers for Disease Control and Prevention, Division of Laboratory Systems (CDC DLS), focused on laboratory tests and how testing processes can be designed to benefit patient care. In collaboration with CDC DLS, the American Society for Microbiology (ASM) used an evidence review method developed by the CDC DLS to develop a program for creating laboratory testing guidelines and practices. The CDC DLS method is called the Laboratory Medicine Best Practices (LMBP) initiative and uses the A-6 cycle method. Adaptations made by ASM are called Evidence-based Laboratory Medicine Practice Guidelines (EBLMPG). This review details how the ASM Systematic Review (SR) Processes were developed and executed collaboratively with CDC's DLS. The review also describes the ASM transition from LMBP to the organization's current EBLMPG, maintaining a commitment to working with agencies in the U.S. Department of Health and Human Services and other partners to ensure that EBLMPG evidence is readily understood and consistently used.
{"title":"The American Society for Microbiology collaboration with the CDC Laboratory Medicine Best Practices initiative for evidence-based laboratory medicine.","authors":"Alice S Weissfeld,Vickie Baselski,Nancy E Cornish,Colleen S Kraft,Mark T LaRocco,Peggy McNult,Irving Nachamkin,James Scott Parrott,Sandra S Richter,Matthew Rubinstein,Michael A Saubolle,Robert L Sautter,James W Snyder,Joanna Taliano,Donna M Wolk","doi":"10.1128/cmr.00065-18","DOIUrl":"https://doi.org/10.1128/cmr.00065-18","url":null,"abstract":"SUMMARYClinical medicine has embraced the use of evidence for patient treatment decisions; however, the evaluation strategy for evidence in laboratory medicine practices has lagged. It was not until the end of the 20th century that the Institute of Medicine (IOM), now the National Academy of Medicine, and the Centers for Disease Control and Prevention, Division of Laboratory Systems (CDC DLS), focused on laboratory tests and how testing processes can be designed to benefit patient care. In collaboration with CDC DLS, the American Society for Microbiology (ASM) used an evidence review method developed by the CDC DLS to develop a program for creating laboratory testing guidelines and practices. The CDC DLS method is called the Laboratory Medicine Best Practices (LMBP) initiative and uses the A-6 cycle method. Adaptations made by ASM are called Evidence-based Laboratory Medicine Practice Guidelines (EBLMPG). This review details how the ASM Systematic Review (SR) Processes were developed and executed collaboratively with CDC's DLS. The review also describes the ASM transition from LMBP to the organization's current EBLMPG, maintaining a commitment to working with agencies in the U.S. Department of Health and Human Services and other partners to ensure that EBLMPG evidence is readily understood and consistently used.","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"3 1","pages":"e0006518"},"PeriodicalIF":36.8,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142321037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zehan PangAo TangYujie HeJunfen FanQingmao YangYigang TongHuahao Fan1College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China2Department of Neurology, Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China3School of Life Sciences, Tianjin University, Tianjin, ChinaGraeme N. Forrest
Clinical Microbiology Reviews, Ahead of Print.
临床微生物学评论》，提前出版。
{"title":"Neurological complications caused by SARS-CoV-2","authors":"Zehan PangAo TangYujie HeJunfen FanQingmao YangYigang TongHuahao Fan1College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China2Department of Neurology, Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China3School of Life Sciences, Tianjin University, Tianjin, ChinaGraeme N. Forrest","doi":"10.1128/cmr.00131-24","DOIUrl":"https://doi.org/10.1128/cmr.00131-24","url":null,"abstract":"Clinical Microbiology Reviews, Ahead of Print. <br/>","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"4 1","pages":""},"PeriodicalIF":36.8,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142245271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jaffar A. Al-TawfiqStanley M. Spinola1Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia2Department of Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA3Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA4Department of Microbiology and Immunology, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA5Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USAGraeme N. Forrest
Clinical Microbiology Reviews, Ahead of Print.
临床微生物学评论》，提前出版。
{"title":"Infections caused by Haemophilus ducreyi: one organism, two stories","authors":"Jaffar A. Al-TawfiqStanley M. Spinola1Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia2Department of Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA3Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA4Department of Microbiology and Immunology, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA5Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USAGraeme N. Forrest","doi":"10.1128/cmr.00135-24","DOIUrl":"https://doi.org/10.1128/cmr.00135-24","url":null,"abstract":"Clinical Microbiology Reviews, Ahead of Print. <br/>","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"13 1","pages":""},"PeriodicalIF":36.8,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142236278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：